In accordance with Article 13(2) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge, it is necessary to amend the conditions of approval of dicamba, difenoconazole and imazaquin. It is, in particular, appropriate to require further confirmatory information.
Recital 5, Commission Implementing Regulation (EU) No 1100/2011 of 31 October 2011 amending Impleme…
In forcesince 31 Oct 2011